D. E. Shaw & Co., Inc. Bio N Tech Se Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 200,800 shares of BNTX stock, worth $22.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

200,800

Holding current value

$22.7 Million

% of portfolio

0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $2.37 Million - $3.76 Million	-30,202 Reduced 44.06%	38,345 $4.55 Million
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $3.12 Million - $4 Million	38,881 Added 131.06%	68,547 $5.51 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $2.81 Million - $3.55 Million	-31,615 Reduced 51.59%	29,666 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $1.79 Million - $2.22 Million	19,705 Added 47.4%	61,281 $6.47 Million
Q3 2023 Nov 14, 2023	BUY	$98.5 - $125.08 $332,536 - $422,270	3,376 Added 8.84%	41,576 $4.52 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $3.29 Million - $4.16 Million	32,113 Added 527.57%	38,200 $4.12 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $7.73 Million - $9.7 Million	-63,096 Reduced 91.2%	6,087 $758,000
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $4.87 Million - $7.65 Million	-41,132 Reduced 37.29%	69,183 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $29.9 Million - $42.9 Million	-234,278 Reduced 67.99%	110,315 $14.9 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $31.9 Million - $48.3 Million	-259,085 Reduced 42.92%	344,593 $51.4 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $40.5 Million - $74.3 Million	320,584 Added 113.24%	603,678 $103 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $1.88 Million - $3.14 Million	8,655 Added 3.15%	283,094 $73 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $54.7 Million - $119 Million	265,493 Added 2967.73%	274,439 $74.9 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $58,133 - $123,884	-513 Reduced 5.42%	8,946 $2 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $3.98 Million - $5.55 Million	-46,439 Reduced 83.08%	9,459 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $4.06 Million - $7.24 Million	55,898 New	55,898 $4.56 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account